|
NAC response
|
|
CA-125, n (%)
|
|
CA-125 after 3rd NAC < 35
|
49 (31.8)
|
|
CA-125 reduction rate ≥ 90%
|
61 (39.6)
|
|
Response rate after 3rd NAC, n (%)
|
|
CR
|
2 (1.3)
|
|
PR
|
98 (63.6)
|
|
SD
|
21 (13.6)
|
|
PD
|
7 (4.5)
|
|
Unknown
|
26 (16.9)
|
|
Surgical outcome
|
|
Surgery extent, n (%)
|
|
Standard
|
82 (53.3)
|
|
Radical
|
69 (44.8)
|
|
Not surgery
|
3 (1.9)
|
|
Residual disease after IDS, n (%)
|
|
≤1 cm
|
103 (66.9)
|
|
>1 cm
|
25 (16.2)
|
|
Unknown
|
26 (16.9)
|
|
Lymphadenectomy, n (%)
|
|
(−)
|
36 (23.4)
|
|
(+)
|
115 (74.7)
|
|
Unknown
|
3 (1.9)
|
|
Lymph node metastasis, n (%)
|
|
No
|
88 (57.2)
|
|
Yes
|
63 (40.9)
|
|
Unknown
|
3 (1.9)
|
|
Peritoneal cytology, n (%)
|
|
Negative
|
57 (37.0)
|
|
Positive
|
63 (40.9)
|
|
Not tested
|
27 (17.5)
|
|
Unknown
|
7 (4.6)
|
|
Postoperative complications*
|
|
0–2
|
143 (92.9)
|
|
3–5
|
8 (5.2)
|
|
Unknown
|
3 (1.9)
|
